Monoethanolamine

Monoethanolamine

SCHEMBL5507362

COc1ccc2c(NCCO)nc(C#N)c(-c3cccc(F)c3)c2c1.NCCO

nearest known ligand 0.57

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

MPL

The experimentally established mechanism targets of Monoethanolamine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNA5 P22460 7/20 0.57
KCNH2 Q12809 6/20 0.57
SYK P43405 6/20 0.39
KDM4E B2RXH2 2/20 0.38
HTT P42858 1/20 0.38
TAAR1 Q96RJ0 1/20 0.38
ADORA1 P30542 2/20 0.37
RAD52 P43351 2/20 0.37
ALDH1A1 P00352 2/20 0.37
NPSR1 Q6W5P4 1/20 0.37
RXFP1 Q9HBX9 1/20 0.37
KMT2A Q03164 2/20 0.37
POLB P06746 1/20 0.37
MEN1 O00255 1/20 0.36
USP2 O75604 1/20 0.36
LMNA P02545 1/20 0.36
CYP1A2 P05177 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2D6 P10635 1/20 0.36
CYP2C9 P11712 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1382414 0.96 KCNA5 (0.61) KCNA5KCNH2KDM4EHTTTAAR1
SCHEMBL1385287 0.92 KCNA5 (0.60) KCNA5KCNH2KDM4EADORA1RAD52
SCHEMBL6047735 0.91 KCNA5 (0.59) KCNA5KCNH2SYKKDM4EADORA1
SCHEMBL1382986 0.86 KCNA5 (0.68) KCNA5KCNH2KDM4EALDH1A1NPSR1
SCHEMBL1383316 0.86 KCNA5 (0.68) KCNA5KCNH2KDM4EALDH1A1NPSR1
SCHEMBL1382989 0.86 KCNA5 (0.68) KCNA5KCNH2KDM4EALDH1A1NPSR1
SCHEMBL3120498 0.85 KCNA5 (0.61) KCNA5KCNH2KDM4EHTTTAAR1
SCHEMBL3119826 0.85 KCNA5 (0.54) KCNA5KCNH2KDM4EALDH1A1NPSR1
SCHEMBL1384017 0.84 KCNA5 (0.81) KCNA5KCNH2KDM4EADORA1ALDH1A1
SCHEMBL5500034 0.84 KCNA5 (0.81) KCNA5KCNH2KDM4EADORA1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1667979-A4 ISOQUINOLINE POTASSIUM CHANNEL INHIBITORS MERCK & CO INC (US) 2007-04-18 EP disclosed
EP-1667979-A2 ISOQUINOLINE POTASSIUM CHANNEL INHIBITORS Merck & Co., Inc. (US) 2006-06-14 EP disclosed
WO-2005030130-A2 ISOQUINOLINE POTASSIUM CHANNEL INHIBITORS MERCK & CO., INC. (US) 2005-04-07 WO disclosed